SUPER TASTYLIA

What is SUPER TASTYLIA?

SUPER TASTYLIA is a modern combined medicinal product developed by the pharmaceutical company Healing Pharma for the correction of erectile dysfunction in men. The medication belongs to the pharmacotherapeutic group of phosphodiesterase type 5 (PDE-5) inhibitors, which are considered the gold standard in the treatment of erectile dysfunction. The main active substance is tadalafil — a molecule with proven clinical efficacy and a favorable safety profile. The uniqueness of SUPER TASTYLIA lies in its release form: the drug is presented in the form of oral dispersible strips that dissolve instantly directly in the oral cavity. This format provides rapid absorption of the active component through the mucous membrane, bypassing primary metabolism in the liver.

The pharmacological action of SUPER TASTYLIA is based on the ability of tadalafil to selectively inhibit the phosphodiesterase type 5 enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in the cavernous bodies of the penis. An increase in cGMP concentration causes relaxation of vascular smooth muscle, increased arterial blood flow, and the formation of a stable erection, provided that sexual stimulation is present. It is important to understand that the medication does not cause an erection without natural arousal, but only enhances the body's physiological response to sexual stimuli. This mechanism of action is as close as possible to natural processes, which favorably distinguishes tadalafil from previous generations of drugs.

Healing Pharma is an Indian pharmaceutical company specializing in the production of high-quality generic drugs in accordance with international GMP standards. The company's products undergo multi-stage quality control at all stages of the production cycle, which guarantees dosage stability and bioavailability of active substances. SUPER TASTYLIA is available in convenient blister packaging that protects the strips from moisture and mechanical damage. Each unit contains a precisely calibrated dose of tadalafil, allowing the patient to easily control the intake of the medication without the need to measure the dosage.

What is SUPER TASTYLIA prescribed for?

The main indication for the use of SUPER TASTYLIA is erectile dysfunction of various origins — a condition in which a man cannot achieve or maintain an erection sufficient for full intercourse. The drug is effective both in psychogenic forms of the disorder associated with stress, anxiety, or performance anxiety, and in organic causes due to vascular, neurological, or hormonal changes. Tadalafil as part of SUPER TASTYLIA demonstrates a stable therapeutic effect regardless of the patient's age and duration of the disease. Clinical studies confirm that the medication restores erectile function in more than 80% of men with various forms of the disorder.

SUPER TASTYLIA is also prescribed for symptoms of benign prostatic hyperplasia, including difficult urination, frequent urge to urinate at night, and a feeling of incomplete bladder emptying. Tadalafil relaxes the smooth muscles not only of the blood vessels of the penis, but also of the prostate gland and bladder neck, which helps improve urodynamics. This dual therapeutic effect makes the drug particularly valuable for men over 50 years of age, in whom erectile dysfunction is often combined with manifestations of prostate adenoma. Treatment with SUPER TASTYLIA allows solving both problems simultaneously without the need to take additional medications.

A separate category of application is rehabilitation of erectile function after radical prostatectomy or other surgical interventions on pelvic organs. Regular intake of low doses of tadalafil helps preserve the elasticity of cavernous tissue and prevents the development of fibrosis in the postoperative period. In addition, SUPER TASTYLIA can be used in the complex therapy of premature ejaculation, as a stable erection reduces psychological tension and prolongs the duration of intercourse. In each case, the appropriateness of the prescription is determined by a physician after a complete examination of the patient.

Composition and active ingredients of SUPER TASTYLIA

The main active substance of SUPER TASTYLIA is tadalafil at a dosage of 20 mg per single oral strip. Tadalafil belongs to selective phosphodiesterase type 5 inhibitors and is characterized by the longest elimination half-life among all drugs in this group — up to 36 hours. Due to this, the therapeutic concentration of the active component is maintained in the blood for a long time, providing the possibility of spontaneous sexual activity without a rigid connection to the time of taking the drug. Tadalafil does not affect libido, testosterone levels, or fertility, but only restores the physiological mechanism of erection.

Auxiliary components of SUPER TASTYLIA oral strips include a polymer base, plasticizers, sweeteners, and flavorings, which ensure a pleasant taste and rapid dissolution of the film in the oral cavity. The technology for manufacturing dispersible strips involves a uniform distribution of tadalafil in the polymer matrix, which guarantees the dosing accuracy of each unit. Unlike traditional tablets, the sublingual form allows the active substance to be absorbed directly through the oral mucosa, bypassing the gastrointestinal tract. This reduces the load on the liver and lowers the risk of dyspeptic disorders characteristic of oral forms of PDE-5 inhibitors.

The mechanism of action of tadalafil is realized through the inhibition of the phosphodiesterase type 5 enzyme, which is found in large quantities in the smooth muscle of cavernous bodies, pulmonary vessels, and the prostate gland. Blocking this enzyme prevents the destruction of cyclic guanosine monophosphate, leading to the accumulation of the latter in cells. High levels of cGMP activate protein kinase G, which triggers a cascade of reactions ending in a decrease in intracellular calcium concentration and relaxation of smooth muscle fibers. The result is vasodilation, increased blood flow in the cavernous bodies, and the formation of a stable erection in the presence of sexual stimulation.

Dosage of SUPER TASTYLIA

The standard recommended dose of SUPER TASTYLIA for adult men is 20 mg of tadalafil, which corresponds to one oral strip taken 30–60 minutes before expected sexual activity. The medication can be used as needed, without being tied to a regular dosing schedule, since the long half-life ensures that the effect lasts up to 36 hours. The maximum recommended frequency of administration is one strip per day; exceeding this dose does not lead to an increase in the therapeutic effect, but significantly increases the risk of side effects. For patients planning regular sexual activity, daily intake of the drug at a dose of 5 mg is possible, but for this purpose, appropriate release forms of tadalafil with a lower dosage should be used.

Dose adjustment of SUPER TASTYLIA is required for patients with impaired kidney or liver function. With a creatinine clearance of 30 to 50 ml/min, it is recommended to reduce the dose to 10 mg once every 48 hours, and in severe renal failure with a clearance below 30 ml/min, the use of tadalafil is contraindicated. Men with mild to moderate hepatic impairment should start therapy with the minimum effective dose and carefully monitor the tolerability of the drug. Dose adjustment is not required for elderly patients; however, due to increased sensitivity to medications, it is recommended to start with half the standard dose.

The duration of the treatment course with SUPER TASTYLIA is determined individually depending on the cause of erectile dysfunction and the body's response to therapy. With situational use, the medication is taken only as needed, without a fixed schedule. In cases where erectile dysfunction is chronic or associated with organic diseases, the doctor may recommend a course of intake for 4–12 weeks with subsequent evaluation of effectiveness. It is important to understand that SUPER TASTYLIA is not a agent for continuous use without medical supervision, and every patient should periodically undergo a follow-up examination.

How to take SUPER TASTYLIA correctly?

SUPER TASTYLIA in the form of an oral strip is taken sublingually or buccally: the strip should be removed from the blister with dry hands and placed under the tongue or behind the cheek, where it will completely dissolve within 1–3 minutes. Washing down the medication with water is not required, as the active substance is absorbed through the oral mucosa directly into the systemic circulation. This method of administration provides a faster onset of action compared to tablet forms — the first signs of the effect may appear as early as 15–20 minutes after administration. Food intake does not affect the bioavailability of tadalafil, so SUPER TASTYLIA can be used regardless of meal times, unlike some other PDE-5 inhibitors.

If the patient missed a scheduled dose of SUPER TASTYLIA, they should not double the next dose to compensate for the missed one. In case of situational use of the drug, the omission has no clinical significance, as the medication is taken only as needed. With regular course treatment, a missed dose should be taken as soon as possible if more than 12 hours remain until the next scheduled dose. It is important not to exceed the maximum daily dose of 20 mg, as accumulation of tadalafil in the body can lead to increased side effects without improving the therapeutic result.

Before starting the use of SUPER TASTYLIA, it is necessary to undergo a medical examination to rule out contraindications and assess cardiovascular risk. Patients with heart disease should remember that sexual activity itself creates a burden on the cardiovascular system, and taking the drug does not eliminate this risk. During therapy, it is recommended to refrain from consuming grapefruit juice, which can affect the metabolism of tadalafil and increase its concentration in the blood. The drug should be stored in a dry place at a temperature not exceeding 25 degrees Celsius, avoiding direct sunlight and access by children.

Side effects of SUPER TASTYLIA

The most common side effects of SUPER TASTYLIA are headache, dyspepsia, back pain, myalgia, nasal congestion, and hot flashes. These reactions occur in 5–15% of patients and are usually mild to moderate in nature, do not require discontinuation of the drug, and disappear on their own within 12–48 hours after administration. Headache is caused by vasodilation of cerebral vessels, while myalgia and back pain are associated with the effect of tadalafil on skeletal muscle. Dyspeptic phenomena, such as nausea or a feeling of heaviness in the epigastrium, occur less frequently due to the sublingual route of administration, which bypasses the stomach.

Uncommon adverse reactions include dizziness, palpitations, increased blood pressure, tinnitus, visual disturbances, including changes in color perception and increased sensitivity to light. Rare but serious complications are priapism — a prolonged painful erection lasting more than 4 hours, sudden loss of vision or hearing, as well as severe allergic reactions. Priapism is an emergency condition that requires immediate medical attention, as prolonged circulatory disturbance in the cavernous bodies can lead to irreversible tissue damage and permanent impotence. The patient must be informed of these risks before starting therapy.

An individual's body reaction to SUPER TASTYLIA may vary depending on age, concomitant diseases, genetic characteristics of metabolism, and simultaneous administration of other medications. It is necessary to consult a doctor in cases where side effects persist for more than 48 hours, worsen with each dose, or significantly impair the quality of life. Particular attention is required for cardiovascular symptoms, such as chest pain, severe shortness of breath, or cardiac arrhythmias occurring during or after sexual activity. In such situations, you should immediately stop using the drug and seek emergency medical assistance.

Contraindications of SUPER TASTYLIA

An absolute contraindication to the use of SUPER TASTYLIA is the simultaneous administration of nitrates in any dosage form — nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, and other nitric oxide donors. The combination of tadalafil with nitrates causes a life-threatening drop in blood pressure, which can lead to collapse, myocardial infarction, or stroke. Patients taking nitrates to treat angina pectoris are strictly prohibited from using SUPER TASTYLIA even in minimal doses. The medication is also contraindicated in men with hypersensitivity to tadalafil or any auxiliary component of the oral strips.

SUPER TASTYLIA is not prescribed to patients with severe cardiovascular diseases for which sexual activity poses a health risk. This category includes recent myocardial infarction within the last 90 days, unstable angina, heart failure of NYHA functional class II–IV, uncontrolled arrhythmias, and arterial hypotension with pressure below 90/50 mm Hg. Severe renal failure with a creatinine clearance of less than 30 ml/min is also a contraindication, as the excretion of the drug in such patients is significantly slowed down. The drug is not used in persons under 18 years of age due to the lack of safety and efficacy data in this age group.

A separate group consists of relative contraindications in which SUPER TASTYLIA can be used only after a thorough assessment of the benefit-risk ratio. These include anatomical deformation of the penis, such as Peyronie's disease or cavernosal angiofibrosis, as well as conditions that increase the risk of priapism: sickle cell anemia, leukemia, multiple myeloma. Patients with retinitis pigmentosa should use the drug with caution due to the potential effect on retinal phosphodiesterase enzymes. For men who have suffered a stroke or transient ischemic attack within the last 6 months, the prescription of tadalafil is possible only after consulting a neurologist.

Interaction of SUPER TASTYLIA with other drugs and alcohol

The most dangerous drug interaction of SUPER TASTYLIA is the combination with nitrates and nitric oxide donors, which leads to a critical drop in blood pressure. Tadalafil also enhances the hypotensive effect of alpha-blockers used in prostatic hyperplasia, so the combination of these drugs requires careful dose selection under medical supervision. Inhibitors of the CYP3A4 isoenzyme, such as ketoconazole, itraconazole, ritonavir, and erythromycin, slow down the metabolism of tadalafil in the liver, increasing its concentration in the blood and the risk of side effects. At the same time, CYP3A4 inducers, in particular rifampicin, carbamazepine, and phenytoin, accelerate the excretion of the drug and reduce its therapeutic efficacy.

Alcohol consumption during SUPER TASTYLIA therapy is acceptable in moderate amounts; however, it should be borne in mind that ethanol itself has a vasodilating effect and can enhance the hypotensive effect of tadalafil. Excessive alcohol consumption increases the risk of orthostatic hypotension, dizziness, and headaches, and negatively affects the ability to achieve an erection, neutralizing the therapeutic effect of the drug. Patients are recommended to limit alcohol consumption to 1–2 standard drinks per day and avoid strong spirits on the day of taking the medication. The effect of SUPER TASTYLIA on the ability to drive vehicles is minimal, but if dizziness or visual disturbances occur, you should refrain from driving until the symptoms completely disappear.

Where to buy SUPER TASTYLIA in Ukraine

SUPER TASTYLIA is available for purchase in pharmacy chains in Ukraine with a prescription from a doctor, as the drug belongs to the prescription group of medicines. Before purchasing, it is recommended to check the availability of the product in a specific pharmacy, as Healing Pharma products may not be presented in all retail outlets. The cost of SUPER TASTYLIA varies depending on the region, pharmacy chain, and number of strips in the package, so it is advisable to compare prices from several sources before buying. The originality of the drug is guaranteed only if purchased from licensed pharmacy establishments or official distributors of the manufacturer.

SUPER TASTYLIA must be stored in its original blister packaging at a temperature from 15 to 25 degrees Celsius in a place protected from moisture and direct sunlight. The shelf life of the drug is usually 24–36 months from the date of production, after which use is strictly prohibited. Some online pharmacies offer a home delivery service for the drug, which is a convenient option for patients who value privacy and saving time. Before ordering online, you should make sure that the pharmacy has an appropriate license for the retail sale of medicines, and the drug is accompanied by instructions in Ukrainian.